As pharmaceutical companies adopt AI technologies ... The preparation of the Common Technical Document (CTD), a mandatory component involving extensive data compilation for regulatory submissions ...

Using glucocorticoids, rituzimab, or certain immunosuppressants to treat connective tissue diseases is associated with ...

Bryan O’Donnell, Head of Quality at Gaelic Laboratories, explains how to navigate GMP challenges to ensure your company ...

Pharma Tech Industries, a global provider of contract manufacturing and packaging solutions for pharmaceutical, medical ...

In winning the competition, Player 831 hopes to fund critical research, drug development, clinical trials, and resources for ...

Nuvectis Pharma, Inc. FORT LEE, NJ, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (Nasdaq: NVCT), a clinical-stage biopharmaceutical company focused on the development of innovative ...

As blockchain expands its reach across different industries, Gunjan Bhardwaj examines some of its practical applications in the pharma industry. Blockchain is quickly increasing in interest and ...

FORT LEE, NJ, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (Nasdaq: NVCT), a clinical-stage biopharmaceutical company focused on the development of innovative precision medicines for ...

FORT LEE, NJ, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (Nasdaq: NVCT), a clinical-stage biopharmaceutical company focused on the development of innovative precision medicines for ...

From the beginning, Player 831 (Jeff Allen) has been upfront about his mission: to win the money and find a cure for his son’s CTD (Creatine Transporter Deficiency). This genetic disorder is ...

Nuvectis Pharma, Inc. announced the successful completion of its public offering of 2,700,000 shares of common stock at $5.00 per share, along with the full exercise of an underwriters' option for ...